Abstract
Jacqueline Chyr, Xi Xian Chen
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Exploring 3D chromatin contacts in gene regulation: The evolution of approaches for the identification of functional enhancer-promoter interaction
2020 · 50 citations
The hierarchical folding dynamics of topologically associating domains are closely related to transcriptional abnormalities in cancers
2021 · 0 citations
No local citing links have been materialized yet.
10.1126/science.1181369
10.1126/science.1181369
Subtle changes in chromatin loop contact propensity are associated with differential gene regulation and expression
10.1038/s41467-019-08940-5 · 2019
10.1016/j.csbj.2020.02.013
10.1016/j.csbj.2020.02.013
Free energy-based model of CTCF-mediated chromatin looping in the human genome
10.1016/j.ymeth.2020.05.025 · 2020
10.1080/19491034.2017.1389365
10.1080/19491034.2017.1389365
10.1038/s41586-019-1778-y
10.1038/s41586-019-1778-y
10.1038/nrm.2017.94
10.1038/nrm.2017.94
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers
10.1038/s41467-019-09937-w · 2019
10.1016/j.csbj.2021.03.018
10.1016/j.csbj.2021.03.018
Histone sumoylation and chromatin dynamics
10.1093/nar/gkab280 · 2021
The hierarchical folding dynamics of topologically associating domains are closely related to transcriptional abnormalities in cancers
2021
10.1126/science.1067799
10.1126/science.1067799
10.1016/j.ymeth.2012.05.001
10.1016/j.ymeth.2012.05.001
10.1016/j.ymeth.2020.10.010
10.1016/j.ymeth.2020.10.010
10.1038/nature11082
10.1038/nature11082
10.1016/j.molcel.2016.05.018
10.1016/j.molcel.2016.05.018
10.1016/j.cell.2014.11.021
10.1016/j.cell.2014.11.021
10.1093/nar/gkv1505
10.1093/nar/gkv1505
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
10.1038/s41467-019-14098-x · 2020
10.1016/j.molcel.2019.05.032
10.1016/j.molcel.2019.05.032
10.1038/s41576-019-0128-0
10.1038/s41576-019-0128-0
10.1093/nar/gkx738
10.1093/nar/gkx738
10.1186/s13059-015-0740-z
10.1186/s13059-015-0740-z
10.1016/j.gde.2005.08.002
10.1016/j.gde.2005.08.002
Effects of DNA methylation on DNA-binding proteins and gene expression
10.1016/0959-437x(93)90027-m · 1993
10.1101/gr.136101.111
10.1101/gr.136101.111
Integrative modeling reveals the principles of multi-scale chromatin boundary formation in human nuclear organization
10.1186/s13059-015-0661-x · 2015
A computational method to predict topologically associating domain boundaries combining histone Marks and sequence information
2019
Gradient boosting machines, a tutorial
10.3389/fnbot.2013.00021 · 2013
Learning nonlinear functions using regularized greedy forest
10.1109/tpami.2013.159 · 2014
Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study
10.1016/s2214-109x(20)30261-8 · 2020
SEER cancer statistics review
1975
The central role of provider training in implementing resource-stratified guidelines for palliative care in low-income and middle-income countries: lessons from the Jamaica Cancer Care and Research Institute in the Caribbean and Universidad Católica in Latin America
10.1002/cncr.32857 · 2020
10.1158/1055-9965.epi-15-0535
10.1158/1055-9965.epi-15-0535
Unresolved referenced work
2005
Using Convolutional Neural Network with Cheat Sheet and Data Augmentation to Detect Breast Cancer in Mammograms
10.1155/2020/9523404 · 2020
Unresolved referenced work
Kept as external metadata until matched
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
10.1007/s13167-019-00194-x · 2019
10.3390/ijms20122878
10.3390/ijms20122878
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
2020
10.1038/onc.2010.209
10.1038/onc.2010.209 · doi-reference
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer
10.1186/s12885-018-5262-0 · doi-reference
10.1016/j.molmed.2010.12.007
10.1016/j.molmed.2010.12.007 · doi-reference
Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells
10.1002/emmm.201302625 · doi-reference
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts
10.18632/oncotarget.11826 · doi-reference
10.2174/1874467212666190215112915
10.2174/1874467212666190215112915 · doi-reference
Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs)
10.3233/bd-2006-24108 · doi-reference
Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
10.1038/sj.bjc.6603316 · doi-reference
Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
10.1097/cm9.0000000000000923 · doi-reference
10.1371/journal.pone.0113354
10.1371/journal.pone.0113354 · doi-reference
10.1038/nature08497
10.1038/nature08497 · doi-reference
10.1101/gr.101923.109
10.1101/gr.101923.109 · doi-reference
Chromosome structure at micro-scale
10.1038/s41576-020-0243-y · doi-reference
10.1038/nmeth.3329
10.1038/nmeth.3329 · doi-reference
10.1371/journal.pgen.1002610
10.1371/journal.pgen.1002610 · doi-reference
10.1086/511888
10.1086/511888 · doi-reference
Structural maintenance of chromosomes (SMC) proteins: conserved molecular properties for multiple biological functions
10.1046/j.1432-1327.1999.00509.x · doi-reference
10.1038/sj.onc.1204349
10.1038/sj.onc.1204349 · doi-reference
10.1093/nar/28.1.27
10.1093/nar/28.1.27 · doi-reference
10.1186/gb-2003-4-5-p3
10.1186/gb-2003-4-5-p3 · doi-reference
10.1101/gr.201517.115
10.1101/gr.201517.115 · doi-reference
10.1038/nmeth.1923
10.1038/nmeth.1923 · doi-reference
10.1186/gb-2010-11-10-r106
10.1186/gb-2010-11-10-r106 · doi-reference
10.1093/bioinformatics/19.2.185
10.1093/bioinformatics/19.2.185 · doi-reference
Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription
10.1016/j.celrep.2014.06.016 · doi-reference
Whole-genome cartography of estrogen receptor alpha binding sites
10.1371/journal.pgen.0030087 · doi-reference
Estrogen-induced chromatin decondensation and nuclear re-organization linked to regional epigenetic regulation in breast cancer
10.1186/s13059-015-0719-9 · doi-reference
10.1093/nar/gkaa747
10.1093/nar/gkaa747 · doi-reference
10.1016/j.ymeth.2019.08.004
10.1016/j.ymeth.2019.08.004 · doi-reference
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays
10.1186/bcr2121 · doi-reference
10.1158/0008-5472.can-08-3907
10.1158/0008-5472.can-08-3907 · doi-reference
10.1038/nature11412
10.1038/nature11412 · doi-reference
10.1016/j.molonc.2010.04.002
10.1016/j.molonc.2010.04.002 · doi-reference
10.1086/375033
10.1086/375033 · doi-reference
10.1093/jnci/djaa040
10.1093/jnci/djaa040 · doi-reference